FDA Inspection 1282788 — Catalent Pharma Solutions, LLC

Catalent Pharma Solutions, LLC — FEI 1811396

The FDA completed an inspection of Catalent Pharma Solutions, LLC on January 30, 2026 in Saint Petersburg, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 30, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saint Petersburg, FL (United States)